You are here

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020187029
Dec 20203806
Jan 202148013
Feb 2021104018
Mar 2021190028
Apr 2021204024
May 202183021
Jun 20210019
Jul 20210013
Aug 20210011
Sep 20210012
Oct 202194024
Nov 2021183028
Dec 2021122013
Jan 20229002
Feb 2022112035
Mar 2022130015
Apr 2022114013
May 2022108013
Jun 202296016
Jul 202215809
Aug 202286010
Sep 202298010
Oct 20227404
Nov 2022118017
Dec 202210605
Jan 2023140022
Feb 202396011
Mar 20238806
Apr 202314009
May 202376012
Jun 2023112017
Jul 202398012
Aug 2023200021
Sep 20239809
Oct 202384013
Nov 202310809
Dec 20238007
Jan 20243403
Feb 202412006
Mar 202413806
Apr 2024138012
May 2024102011
Jun 2024102016
Jul 202410208
Aug 20245205
Sep 202410008
Oct 2024100010
Nov 20248407
Dec 2024112015
Jan 20258409
Feb 202514010
Mar 2025006
Apr 20250011
May 2025006
Jun 2025007
Total51450712